HK1255702A1 - 用於合成顯像劑的自動反應系統，暗盒和裝置 - Google Patents

用於合成顯像劑的自動反應系統，暗盒和裝置

Info

Publication number
HK1255702A1
HK1255702A1 HK18114852.8A HK18114852A HK1255702A1 HK 1255702 A1 HK1255702 A1 HK 1255702A1 HK 18114852 A HK18114852 A HK 18114852A HK 1255702 A1 HK1255702 A1 HK 1255702A1
Authority
HK
Hong Kong
Prior art keywords
cassette
reaction system
imaging agents
automated reaction
synthesizing imaging
Prior art date
Application number
HK18114852.8A
Other languages
English (en)
Inventor
Richard R Cesati
Edward H Cheesman
Joel Lazewatsky
Heike S Radeke
James F Castner
Enrico Mongeau
Dianne D Zdankiewicz
Robert Wilburn Siegler
Marybeth Devine
Original Assignee
Lantheus Medical Imaging Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantheus Medical Imaging Inc filed Critical Lantheus Medical Imaging Inc
Publication of HK1255702A1 publication Critical patent/HK1255702A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C07D237/16—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cameras In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK18114852.8A 2010-02-08 2018-11-21 用於合成顯像劑的自動反應系統，暗盒和裝置 HK1255702A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30247710P 2010-02-08 2010-02-08
US31537610P 2010-03-18 2010-03-18
US33369310P 2010-05-11 2010-05-11

Publications (1)

Publication Number Publication Date
HK1255702A1 true HK1255702A1 (zh) 2019-08-23

Family

ID=44356121

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114852.8A HK1255702A1 (zh) 2010-02-08 2018-11-21 用於合成顯像劑的自動反應系統，暗盒和裝置

Country Status (20)

Country Link
US (5) US8936777B2 (zh)
EP (3) EP4046990A1 (zh)
JP (3) JP6092628B2 (zh)
KR (5) KR20180055933A (zh)
CN (3) CN113058046A (zh)
AU (3) AU2011213568B2 (zh)
BR (1) BR112012019789A2 (zh)
CA (1) CA2789044C (zh)
DK (2) DK2534136T3 (zh)
ES (2) ES2909318T3 (zh)
HK (1) HK1255702A1 (zh)
IL (2) IL221253B (zh)
MX (1) MX348958B (zh)
NO (1) NO2534136T3 (zh)
NZ (1) NZ602291A (zh)
PT (2) PT3323810T (zh)
RU (1) RU2631500C2 (zh)
SG (2) SG10201500929XA (zh)
TW (4) TWI660947B (zh)
WO (1) WO2011097649A2 (zh)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US7485283B2 (en) 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
AU2007339954B2 (en) 2006-12-26 2013-06-20 Lantheus Medical Imaging, Inc. Ligands for imaging cardiac innervation
CA2967254C (en) 2008-02-29 2019-03-26 Lantheus Medical Imaging, Inc. Contrast agents for applications including imaging cancer
DK2419096T3 (da) 2009-04-15 2020-02-03 Lantheus Medical Imaging Inc Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre
US10109385B2 (en) 2009-09-23 2018-10-23 Abt Molecular Imaging, Inc. Dose synthesis card for use with automated biomarker production system
CN113058046A (zh) 2010-02-08 2021-07-02 兰休斯医疗成像公司 用于合成显像剂和其中间体的方法和装置
BR122020018186B1 (pt) 2010-05-11 2021-07-27 Lantheus Medical Imaging, Inc Uso de agentes de imagiologia para preparação de uma composição para detecção do transportador de norepinefrina (net) e método para a detecção de net
EP2704577A4 (en) * 2011-05-05 2014-10-15 Cedars Sinai Medical Center EVALUATION OF A CORONARY HEART DISEASE WITH CARBON DIOXIDE
US11129911B2 (en) 2011-05-05 2021-09-28 Cedars-Sinai Medical Center Assessment of coronary heart disease with carbon dioxide
SG2014013767A (en) * 2011-09-09 2014-05-29 Lantheus Medical Imaging Inc Compositions, methods, and systems for the synthesis and use of imaging agents
US20140328757A1 (en) * 2011-10-21 2014-11-06 Lantheus Medical Imaging, Inc. Compositions comprising ascorbic acid and an imaging agent and related methods
US20150023873A1 (en) 2011-11-11 2015-01-22 Lantheus Medical Imaging, Inc. Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging
EP2836241B1 (en) 2012-04-10 2019-02-20 Lantheus Medical Imaging, Inc. Radiopharmaceutical synthesis methods
CA2794281C (en) * 2012-04-30 2019-07-02 Elazar A. Bienenstock Single photon emission computed tomography imaging method
US9789211B2 (en) 2012-05-14 2017-10-17 University Of Southern California Methods and compositions for positron emission tomography myocardial perfusion imaging
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
US10471094B2 (en) 2013-08-05 2019-11-12 Cedars-Sinai Medical Center Methods for reducing ischemia-reperfusion injury via targeted control of blood gases
JP6190240B2 (ja) 2013-10-16 2017-08-30 浜松ホトニクス株式会社 癌に対する治療効果の診断剤
US9031300B1 (en) 2013-10-25 2015-05-12 General Electric Company System and method reconstructing a nuclear medicine image using deformed attenuation image
CN107530455A (zh) * 2015-02-10 2018-01-02 Abt分子成像公司 与自动化生物标记物生产系统联用的剂量合成卡
NL2014828B1 (en) * 2015-05-20 2017-01-31 Out And Out Chemistry S P R L Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method.
CN105553594B (zh) * 2015-12-09 2018-02-16 沈阳东软医疗系统有限公司 一种pet时钟同步方法和装置
WO2017180492A1 (en) * 2016-04-11 2017-10-19 The General Hospital Corporation System and method for quantitatively mapping mitochondrial membrane potential
JP6060302B1 (ja) * 2016-06-10 2017-01-11 日本メジフィジックス株式会社 心筋核医学画像データの解析方法及び解析装置
TWI649067B (zh) * 2017-03-01 2019-02-01 醫百科技股份有限公司 Positioning corrector
CN108129673B (zh) * 2017-12-26 2020-10-13 武汉大学 一种高灵敏度水溶性树枝状大分子f19显影剂的制备及其应用
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction
CN108658868A (zh) * 2018-05-07 2018-10-16 四川大学 一种碳酸氢盐离子液体及其制备方法以及一种三氨基三硝基苯的重结晶方法
EP3671511B1 (en) 2018-12-19 2022-07-06 Rohde & Schwarz GmbH & Co. KG Communication system and method
CN109806822B (zh) * 2019-01-30 2021-07-30 杭州吉蕊科技有限公司 一种模块化、多功能的pet探针自动化合成系统
CN109896934A (zh) * 2019-03-08 2019-06-18 山东省药学科学院 一种高纯度2-苄氧基溴乙烷的制备方法
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
GB201919016D0 (en) * 2019-12-20 2020-02-05 Ge Healthcare Ltd Apparatus and method for solid phase extraction
CN111333638A (zh) * 2020-03-17 2020-06-26 四川大学华西医院 18f标记的异喹啉并哒嗪酮类化合物及其合成方法和应用
JP7362561B2 (ja) * 2020-07-30 2023-10-17 富士フイルム株式会社 放射線画像処理装置、方法およびプログラム
CA3208261A1 (en) * 2021-06-11 2022-12-15 Albert SINUSAS Non-invasive imaging methods of diagnosing peripheral arterial disease
GB202108608D0 (en) 2021-06-16 2021-07-28 Ge Healthcare Ltd Preparation of a ph-adjusted ascorbic acid solution
GB202108605D0 (en) 2021-06-16 2021-07-28 Ge Healthcare Uk Ltd Effect of water content
CN116351339A (zh) * 2022-06-07 2023-06-30 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114716415B (zh) * 2022-06-09 2022-09-02 北京先通国际医药科技股份有限公司 生产液体组合物的设备及其制备方法和用途
CN114732918B (zh) * 2022-06-10 2022-09-13 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114773179B (zh) * 2022-06-23 2022-09-16 北京先通国际医药科技股份有限公司 一种化合物ⅰ液体组合物的制备方法、及其在心肌代谢pet显像上的用途

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1073999A (en) 1965-01-29 1967-06-28 Ncr Co Process for forming stable images in photochromic material
US4510125A (en) 1982-12-08 1985-04-09 Mallinckrodt, Inc. Process for making lyophilized radiographic imaging kit
JPS604173A (ja) 1983-06-23 1985-01-10 Nissan Chem Ind Ltd ピリダジノン誘導体，その製造法および殺虫・殺ダニ・殺菌剤
EP0169375B1 (en) 1984-06-23 1989-12-20 Nissan Chemical Industries Ltd. Process for producing 2-tert.-butyl-4,5-dichloro-3(2h)-pyridazinone
JPH07116161B2 (ja) 1984-07-04 1995-12-13 日産化学工業株式会社 ピリダジノン誘導体
JPS61130275A (ja) 1984-11-29 1986-06-18 Nissan Chem Ind Ltd ピリダジノン誘導体，その製造法および殺虫・殺ダニ・殺菌剤
DE3578304D1 (de) 1984-11-29 1990-07-26 Nissan Chemical Ind Ltd Pyridazinonderivate, deren herstellung und insektizidische, acaricidische, nematicidische, fungizidische zusammensetzungen.
EP0186817B1 (en) 1984-12-10 1989-08-02 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
US5393512A (en) 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
JPH0641454B2 (ja) 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
JPS61260018A (ja) * 1985-05-14 1986-11-18 Nissan Chem Ind Ltd 抗アレルギ−剤
YU134686A (en) 1985-07-30 1988-02-29 Nissan Chemical Ind Ltd Process for preparing new derivatives 3-(2h)-pyridazinone
JPH0739397B2 (ja) 1985-07-30 1995-05-01 日産化学工業株式会社 ピリダジノン誘導体および害虫防除剤
WO1987002893A1 (en) 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
JPS6315974A (ja) 1986-07-09 1988-01-23 小泉コンピユ−タ−株式会社 ボ−リングゲ−ム点数表表示装置
US5252317A (en) 1986-11-10 1993-10-12 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid
US5567411A (en) 1986-11-10 1996-10-22 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group
JPS63159372A (ja) 1986-12-24 1988-07-02 Nissan Chem Ind Ltd ピリダジノン化合物および殺虫、殺ダニ、殺線虫剤
JPS63159374A (ja) 1986-12-24 1988-07-02 Nissan Chem Ind Ltd ピリダジノン誘導体および殺虫、殺ダニ、殺線虫剤
JPS63159373A (ja) 1986-12-24 1988-07-02 Nissan Chem Ind Ltd ピリダジノン類および殺虫、殺ダニ、殺線虫剤
DE3824210A1 (de) 1988-07-16 1990-01-18 Basf Ag 3(2h)-pyridazinonderivate zur bekaempfung von schnecken
IT1229684B (it) 1989-04-05 1991-09-06 Mini Ricerca Scient Tecnolog Piridazinoni ad attivita' insetticida ed acaricida
JPH02279676A (ja) 1989-04-19 1990-11-15 Otsuka Chem Co Ltd ピリダジノン誘導体
US5087440A (en) 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
GB8923843D0 (en) 1989-10-23 1989-12-13 Salutar Inc Compounds
US5377681A (en) 1989-11-13 1995-01-03 University Of Florida Method of diagnosing impaired blood flow
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5228446A (en) 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5088499A (en) 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5679810A (en) 1990-01-19 1997-10-21 Salutar, Inc. Linear oligomeric polychelant compounds
JPH03220177A (ja) 1990-01-25 1991-09-27 Nissan Chem Ind Ltd 殺虫、殺ダニ剤組成物
WO1992017215A1 (en) 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
GB9006977D0 (en) 1990-03-28 1990-05-23 Nycomed As Compositions
JPH04235975A (ja) 1991-01-21 1992-08-25 Nissan Chem Ind Ltd ピリダジノン誘導体および害虫防除剤
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5093105A (en) 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5306482A (en) 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
DE69231469T2 (de) 1991-08-29 2001-01-25 Mallinckrodt Medical Inc Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
US5169942A (en) 1991-11-21 1992-12-08 General Electric Company Method for making 2-(18F)fluoro-2-deoxy-D-glucose
EP0627424A4 (en) 1992-12-03 1995-03-29 Otsuka Kagaku Kk PYRIDAZINE DERIVATIVES AND INCENTICIDES AND MITICIDES.
US5760191A (en) 1993-02-05 1998-06-02 Nycomed Imaging As Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods
WO1994021653A1 (en) 1993-03-22 1994-09-29 General Electric Company Method for making 2-fluoro-2-deoxyglucose
AU6493894A (en) 1993-03-31 1994-10-24 Mallinckrodt Medical, Inc. Radiopharmaceutical formulations having non-stannous reductants
US5417959A (en) 1993-10-04 1995-05-23 Mallinckrodt Medical, Inc. Functionalized aza-crytand ligands for diagnostic imaging applications
US5493026A (en) 1993-10-25 1996-02-20 Organix, Inc. Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
EP0665223A1 (en) 1994-01-28 1995-08-02 Takeda Chemical Industries, Ltd. Antitumor agent, novel 3(2H)-pyridazinone derivatives and their preparation
JPH07252236A (ja) 1994-01-28 1995-10-03 Takeda Chem Ind Ltd 抗癌剤
JPH10501218A (ja) 1994-06-03 1998-02-03 マリンクロッド・メディカル・インコーポレイテッド 迅速に消失するテクネチウム−９９ｍホスホネート骨格イメージング剤
US5520904A (en) 1995-01-27 1996-05-28 Mallinckrodt Medical, Inc. Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging
EP0727225A3 (en) 1995-02-14 1997-01-15 Sonus Pharma Inc Compositions and methods for directed ultrasonic imaging
US5587491A (en) 1995-03-15 1996-12-24 Regents Of The University Of Minnesota Method for the synthesis of bis-tetrahydrofuranyl Annonaceous acetogenins
US5801228A (en) 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
US5811073A (en) 1995-06-19 1998-09-22 President And Fellows Of Harvard College Method for radioisotopic detection and localization of inflammation in a host
US5827073A (en) 1995-07-05 1998-10-27 Ludwig Institute For Cancer Research Photoreactive peptide derivatives
US6066309A (en) 1996-02-02 2000-05-23 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
US5804161A (en) 1996-05-14 1998-09-08 Nycomed Salutar Inc. Contrast agents
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6565889B2 (en) 1996-12-02 2003-05-20 The Regents Of The University Of California Bilayer structure which encapsulates multiple containment units and uses thereof
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
WO2000009115A1 (en) 1998-08-14 2000-02-24 Smithkline Beecham Corporation Grp receptor ligands
US6056939A (en) 1998-08-28 2000-05-02 Desreux; Jean F. Self-assembling heteropolymetallic chelates as imaging agents and radiopharmaceuticals
AU1309100A (en) 1998-09-29 2000-04-17 Merck & Co., Inc. Radiolabeled neurokinin-1 receptor antagonists
US6645508B1 (en) 1999-06-18 2003-11-11 Jivn-Ren Chen Stable L-ascorbic acid composition
AU2001261728A1 (en) 2000-05-17 2001-11-26 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
GB0019357D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines
WO2002020008A1 (en) 2000-09-06 2002-03-14 The Scripps Research Institute Inhibitors of nadh:ubiquinone oxidoreductase
TWI247609B (en) 2001-01-23 2006-01-21 Nihon Mediphysics Co Ltd Agent for diagnosis of tissue proliferation activity or the treatment of proliferative disease
GB0115927D0 (en) 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US20030044354A1 (en) 2001-08-16 2003-03-06 Carpenter Alan P. Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
US20030082191A1 (en) 2001-08-29 2003-05-01 Poduslo Joseph F. Treatment for central nervous system disorders
AU2002353790A1 (en) * 2001-10-03 2003-04-14 Medical Instill Technologies, Inc. Syringe and reconstitution syringe
JP2005529840A (ja) 2001-10-16 2005-10-06 ヒプニオン， インコーポレイテッド Ｃｎｓ標的モジュレータを使用するｃｎｓ障害の治療
NZ534496A (en) 2002-02-06 2006-08-31 Univ Johns Hopkins Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts
EA009334B1 (ru) 2002-03-29 2007-12-28 Янссен Фармацевтика Н.В. Меченные радиоактивными изотопами производные хинолина и их применение в качестве лигандов метаботропного глутаматного рецептора
AU2003224747A1 (en) 2002-04-08 2003-10-27 Biostream, Inc. Technetium-labeled rotenone derivatives, and methods of use thereof
GB0229683D0 (en) 2002-12-20 2003-01-29 Imaging Res Solutions Ltd Preparation of radiopharmaceuticals
WO2005003100A2 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
WO2005007632A1 (en) 2003-07-18 2005-01-27 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
CA2783275A1 (en) 2003-07-24 2005-02-03 Bracco Imaging S.P.A. Stable radiopharmaceutical compositions and methods for their preparation
GB0317920D0 (en) 2003-07-31 2003-09-03 Amersham Plc Solid-phase synthesis
US7927616B2 (en) 2004-01-16 2011-04-19 Thomas T. Yamashita Pesticide compositions and methods for their use
WO2005082425A1 (en) * 2004-02-24 2005-09-09 The General Hospital Corporation Catalytic radiofluorination
CN1930126A (zh) 2004-03-05 2007-03-14 万有制药株式会社 吡啶酮衍生物
AT500838B1 (de) 2004-04-20 2007-11-15 Veterinaermedizinische Uni Wie Multiple hse
US7485283B2 (en) 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
US20060083681A1 (en) 2004-10-18 2006-04-20 Ajay Purohit Compounds for myocardial perfusion imaging
US7534418B2 (en) 2004-12-10 2009-05-19 The Regents Of The University Of Michigan Imaging agents
KR100789847B1 (ko) 2004-12-15 2007-12-28 (주)퓨쳐켐 알코올 용매하에서 유기플루오로 화합물의 제조방법
JP2009505947A (ja) 2005-06-23 2009-02-12 エモリー・ユニバーシティ 画像化剤
US7824659B2 (en) * 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
JP2007112725A (ja) * 2005-10-18 2007-05-10 Inst Nuclear Energy Research Rocaec 無支持体の１８Ｆで標識したアミノ酸Ｏ−（２−［１８Ｆ］ｆｌｕｏｒｏｅｔｈｙｌ）−Ｌ−Ｔｙｒｏｓｉｎｅの製造方法。
GB0524851D0 (en) * 2005-12-06 2006-01-11 Ge Healthcare Ltd Radiolabelling method using polymers
US7871623B2 (en) * 2005-12-21 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for imaging pain and stress in vivo
US7700616B2 (en) 2006-05-08 2010-04-20 Molecular Neuroimaging, Llc. Compounds and amyloid probes thereof for therapeutic and imaging uses
MX2008016344A (es) 2006-06-21 2009-02-12 Ge Healthcare Ltd Productos radiofarmaceuticos.
CA2657183A1 (en) 2006-08-25 2008-02-28 Boehringer Ingelheim International Gmbh New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds
GB0625523D0 (en) 2006-12-21 2007-01-31 Ge Healthcare Ltd In vivo imaging agents
AU2007339954B2 (en) 2006-12-26 2013-06-20 Lantheus Medical Imaging, Inc. Ligands for imaging cardiac innervation
JP5504563B2 (ja) 2006-12-27 2014-05-28 住友化学株式会社 組成物及び該組成物を用いてなる発光素子
KR101523257B1 (ko) 2007-04-05 2015-05-27 쓰레솔드 파마슈티컬스, 인코포레이티드 니트로-이미다졸 저산소증 영상화제
GB0718386D0 (en) 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
CN101157649A (zh) * 2007-10-23 2008-04-09 江苏省原子医学研究所 18F－Fallypride自动化合成的方法
KR101068835B1 (ko) * 2007-10-26 2011-09-30 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를가지는 이소인돌론 화합물 및 이의 제조 방법
CL2008003785A1 (es) 2007-12-21 2009-10-09 Du Pont Compuestos derivados de piridazina; composiciones herbicidas que comprenden a dichos compuestos; y método para controlar el crecimiento de la vegetación indeseada.
WO2009103478A1 (en) 2008-02-19 2009-08-27 Boehringer Ingelheim International Gmbh Pyridone and pyridazinone derivatives as mch antagonists
WO2010011367A2 (en) 2008-02-22 2010-01-28 Illinois Institute Of Technology Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
CA2967254C (en) 2008-02-29 2019-03-26 Lantheus Medical Imaging, Inc. Contrast agents for applications including imaging cancer
AU2008352050B2 (en) * 2008-03-05 2015-07-02 Rhino Technologies Llc Tensionable spiral bolt with resin nut and related method
US8258134B2 (en) 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
WO2009146388A1 (en) 2008-05-28 2009-12-03 The Trustees Of Columbia University In The City Of New York Voxel-based methods for assessing subjects using positron emission tomography
CA2750579A1 (en) * 2009-02-25 2010-09-02 Focal Technologies Corporation Low-loss collimators for use in fiber optic rotary joints
WO2010104818A1 (en) 2009-03-09 2010-09-16 Bristol-Myers Squibb Company Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
DK2419096T3 (da) 2009-04-15 2020-02-03 Lantheus Medical Imaging Inc Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre
CN101555232B (zh) * 2009-05-21 2011-01-05 北京师范大学 氟-18标记哒嗪酮类化合物及制备方法和应用
WO2011006610A1 (en) 2009-07-11 2011-01-20 Bayer Schering Pharma Aktiengesellschaft Non-polar and polar leaving groups
CN113058046A (zh) 2010-02-08 2021-07-02 兰休斯医疗成像公司 用于合成显像剂和其中间体的方法和装置
BR122020018186B1 (pt) 2010-05-11 2021-07-27 Lantheus Medical Imaging, Inc Uso de agentes de imagiologia para preparação de uma composição para detecção do transportador de norepinefrina (net) e método para a detecção de net
DE102010036356A1 (de) * 2010-07-12 2012-01-12 Abx Advanced Biochemical Compounds Gmbh Vorrichtung zur Synthese radioaktiv markierter Verbindungen
JP5842594B2 (ja) 2010-12-27 2016-01-13 住友化学株式会社 ピリダジノン化合物、それを含有する除草剤及び有害節足動物防除剤
CN102336741B (zh) 2011-07-06 2013-04-10 北京师范大学 氟-18标记的心肌灌注显像剂及其制备方法和应用
SG2014013767A (en) 2011-09-09 2014-05-29 Lantheus Medical Imaging Inc Compositions, methods, and systems for the synthesis and use of imaging agents
US20140328757A1 (en) 2011-10-21 2014-11-06 Lantheus Medical Imaging, Inc. Compositions comprising ascorbic acid and an imaging agent and related methods
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CA2920334A1 (en) 2012-08-13 2014-02-20 The General Hospital Corporation System and method for quantitative mapping of mitocondrial complex 1
US11730430B2 (en) 2012-09-21 2023-08-22 The General Hospital Corporation System and method for single-scan rest-stress cardiac pet

Also Published As

Publication number Publication date
KR20210132243A (ko) 2021-11-03
SG183134A1 (en) 2012-09-27
PT2534136T (pt) 2017-12-15
DK3323810T3 (da) 2022-03-28
IL263543B (en) 2019-08-29
CN102858752A (zh) 2013-01-02
CN109200296B (zh) 2021-12-14
SG10201500929XA (en) 2015-04-29
EP2534136B1 (en) 2017-09-06
EP2534136A2 (en) 2012-12-19
JP6685269B2 (ja) 2020-04-22
IL263543A (en) 2019-01-31
US9603951B2 (en) 2017-03-28
KR20120130293A (ko) 2012-11-30
US10022462B2 (en) 2018-07-17
TW201706252A (zh) 2017-02-16
ES2651466T3 (es) 2018-01-26
EP4046990A1 (en) 2022-08-24
US20130064769A1 (en) 2013-03-14
ES2909318T3 (es) 2022-05-06
DK2534136T3 (en) 2017-12-04
MX2012009174A (es) 2012-11-12
EP3323810B1 (en) 2022-01-05
AU2011213568A1 (en) 2012-09-27
AU2018201916B2 (en) 2020-04-30
KR102438133B1 (ko) 2022-08-31
KR20180055933A (ko) 2018-05-25
EP3323810A3 (en) 2018-07-04
US20210187131A1 (en) 2021-06-24
AU2016213781A1 (en) 2016-09-01
CN113058046A (zh) 2021-07-02
CA2789044A1 (en) 2011-08-11
AU2018201916A1 (en) 2018-04-12
MX348958B (es) 2017-07-04
KR101709372B1 (ko) 2017-02-22
AU2018201916C1 (en) 2020-10-29
PT3323810T (pt) 2022-04-14
US20190290788A1 (en) 2019-09-26
WO2011097649A3 (en) 2011-12-15
AU2011213568B2 (en) 2016-05-12
NZ602291A (en) 2014-10-31
TWI686370B (zh) 2020-03-01
TWI589302B (zh) 2017-07-01
NO2534136T3 (zh) 2018-02-03
US20170258947A1 (en) 2017-09-14
WO2011097649A2 (en) 2011-08-11
TW201134491A (en) 2011-10-16
US8936777B2 (en) 2015-01-20
CA2789044C (en) 2020-09-15
TW201741288A (zh) 2017-12-01
CN109200296A (zh) 2019-01-15
EP3323810A2 (en) 2018-05-23
RU2012138262A (ru) 2014-03-20
IL221253B (en) 2018-12-31
US10842892B2 (en) 2020-11-24
CN102858752B (zh) 2018-10-16
JP2018076328A (ja) 2018-05-17
JP6254126B2 (ja) 2017-12-27
KR20190067255A (ko) 2019-06-14
RU2631500C2 (ru) 2017-09-25
BR112012019789A2 (pt) 2016-08-09
JP2016029059A (ja) 2016-03-03
KR20170033873A (ko) 2017-03-27
IL221253A0 (en) 2012-10-31
JP6092628B2 (ja) 2017-03-08
TWI664169B (zh) 2019-07-01
TWI660947B (zh) 2019-06-01
EP2534136A4 (en) 2013-07-24
TW201843128A (zh) 2018-12-16
US20150165074A1 (en) 2015-06-18
JP2013518913A (ja) 2013-05-23

Similar Documents

Publication Publication Date Title
HK1255702A1 (zh) 用於合成顯像劑的自動反應系統，暗盒和裝置
HRP20182099T1 (hr) Uređaj za dekodiranje slike
GB2485534B (en) Imaging recording apparatus
EP2633678A4 (en) CELLSCOPE DEVICE AND IMAGING METHOD THEREFOR
EP2581028A4 (en) IMAGING DEVICE FOR ENDOSCOPES
PT2648873T (pt) Sistema de imagiologia para remoção de revestimento
LT3051815T (lt) Vaizdo dekodavimo aparatas
HUE046331T2 (hu) Berendezés kép dekódolására
IL214685A0 (en) System and apparatus for horticulture
HK1200399A1 (zh) 用於反應的系統和裝置
EP2598032A4 (en) METHOD AND APPARATUS FOR PROCESSING THE IMAGE AND MEDICAL SYSTEM USING THE SAME
PL2603614T3 (pl) Urządzenie do obróbki futra
EP2536178A4 (en) METHOD, DEVICE AND SYSTEM FOR PROCESSING PRIORITY SERVICES
EP2596320A4 (en) METHOD AND APPARATUS FOR IMAGING
EP2571250A4 (en) IMAGING DEVICE
EP2617183A4 (en) PICTURE SIGNAL PROCESSING DEVICE, PICTURE CHANNELING DEVICE AND METHOD FOR PROCESSING PICTURE SIGNALS
PL2536125T3 (pl) Urządzenie i sposób obrazowania oraz sposób przetwarzania obrazu dla urządzenia obrazującego
IL223049A (en) Methods and ngrf, to inspire chemical reactions by x-ray irradiation
HK1162089A1 (zh) 信息處理設備、信息處理方法
PL2558882T3 (pl) System obrazowania
GB2480864B (en) Processing system for medical scan images
EP2566240A4 (en) METHOD, APPARATUS AND SYSTEM FOR INFORMATION PROCESSING
GB201006180D0 (en) Imaging apparatus
HK1172760A1 (zh) 攝像裝置
HK1159905A1 (en) Imaging apparatus